Negative trials over and over again: How can we do better?
Author:
Affiliation:
1. Center For Neuro-Oncology, Dana-Farber Cancer Institute , Boston , USA
2. Division of Neuro-Oncology, Department of Neurology, Brigham and Women’s Hospital , Boston , USA
3. Harvard Medical School , Boston , USA
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Neurology (clinical),Oncology
Link
https://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noac226/46673555/noac226.pdf
Reference10 articles.
1. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions;Wen;Neuro Oncol.,2020
2. Randomized phase II/III trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed glioblastoma (GBM) patients with MGMT promoter hypermethylation (Alliance A071102);Sarkaria;J Clin Oncol.,2022
3. Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data;Sarkaria;Neuro Oncol.,2018
4. An integrative model of cellular states, plasticity, and genetics for glioblastoma;Neftel;Cell.,2019
5. Dabrafenib plus trametinib in patients with BRAF(V600E)-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial;Wen;Lancet Oncol.,2022
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization;Journal of Clinical Oncology;2023-12-20
2. Methodological and analytical considerations for intra-operative microdialysis;Fluids and Barriers of the CNS;2023-12-19
3. Molecular Profiling and Targeted Therapies in Gliomas;Current Neurology and Neuroscience Reports;2023-10
4. Novel trial designs in neuro-oncology;Current Opinion in Neurology;2023-09-28
5. Aptamers in neuro-oncology: An emerging therapeutic modality;Neuro-Oncology;2023-08-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3